JOHNSON JOHN
SEC insider (Form 3/4/5 filer). CIK 0001410781. Director at Axogen, Inc. (AXGN) and 3 other issuers. 21 reported Form 4/5 transactions since Sep 2024; latest on Jun 24, 2026. Located in CHICAGO, IL.
Companies JOHNSON JOHN has filed insider reports for
- Axogen, Inc. (AXGN): Director
- Xeris Biopharma Holdings, Inc. (XERS): Director
- Verastem, Inc. (VSTM): Director
- Applied Therapeutics, Inc. (APLT): Director, Officer, Executive Chairman
JOHNSON JOHN
CIK: 0001410781
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Discretionary Trading P&L
Holdings
Transaction History (21 total)
- Jun 24, 2026AXGN
Axogen, Inc.
AwardDirectRestricted Stock Units
4.4K shares- - Jun 19, 2026AXGN
Axogen, Inc.
ExerciseDirect14.2K shares- - Jun 4, 2026XERS
Xeris Biopharma Holdings, Inc.
SaleDirect15K shares at avg. $6.09$91K - Jun 4, 2026XERS
Xeris Biopharma Holdings, Inc.
AwardDirect24.2K shares- - May 21, 2026VSTM
Verastem, Inc.
AwardDirect36K shares- - May 7, 2026AXGN
Axogen, Inc.
SaleDirect11.1K shares at avg. $43.26$478K - May 7, 2026AXGN
Axogen, Inc.
ExerciseDirect11.1K shares at avg. $7.04$78K - Dec 19, 2025XERS
Xeris Biopharma Holdings, Inc.
SaleDirect135.4K shares at avg. $7.22$977K - Dec 9, 2025AXGN
Axogen, Inc.
ExerciseDirect8.5K shares at avg. $6.30$54K - Dec 9, 2025AXGN
Axogen, Inc.
SaleDirect8.5K shares at avg. $29.98$256K
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Jun 24, 2026 |  AXGN Axogen, Inc. | Award Restricted Stock Units | 4,392 | - | - | Direct |
| Jun 19, 2026 | AXGN Axogen, Inc. | Exercise | 14,150 | - | $0 | Direct |
| Jun 4, 2026 |  XERS Xeris Biopharma Holdings, Inc. | Sale | 15,000 | $6.09 | $91,422 | Direct |
| Jun 4, 2026 | XERS Xeris Biopharma Holdings, Inc. | Award | 24,193 | - | $0 | Direct |
| May 21, 2026 |  VSTM Verastem, Inc. | Award | 36,000 | - | $0 | Direct |
| May 7, 2026 | AXGN Axogen, Inc. | Sale | 11,050 | $43.26 | $477,968 | Direct |
| May 7, 2026 | AXGN Axogen, Inc. | Exercise | 11,050 | $7.04 | $77,792 | Direct |
| Dec 19, 2025 | XERS Xeris Biopharma Holdings, Inc. | Sale | 135,400 | $7.22 | $977,019 | Direct |
| Dec 9, 2025 | AXGN Axogen, Inc. | Exercise | 8,545 | $6.30 | $53,834 | Direct |
| Dec 9, 2025 | AXGN Axogen, Inc. | Sale | 8,545 | $29.98 | $256,196 | Direct |
1-10 of 21 transactions